Pfizer Inc
Stocks making the biggest moves in the premarket: Nike, Spirit Airlines, Occidental Petroleum and more
Take a look at some of the biggest movers in the premarket: Nike (NKE) – Nike fell 2.4% in premarket trading despite reporting better-than-expected quarterly profit and revenue. The athletic apparel and footwear maker forecast current-quarter revenue below analysts’ estimates amid increased promotional activity and ongoing disruptions in its profitable Chia market. Spirit Airlines (SAVE) […]
Read More
Stocks making the biggest moves premarket: Spirit Airlines, BioNTech, Robinhood and more
Check out the companies making headlines before the bell: Spirit Airlines (SAVE) – Spirit Airlines lost 4.7% in the premarket after saying it would accept the latest improved takeover bid from Frontier Group (ULCC). The latest Frontier cash-and-stock bid is valued at $2.7 billion based on Friday’s closing prices, while the most recent JetBlue (JBLU) […]
Read More
Stocks making the biggest moves premarket: Kellogg, Lennar, Spirit Airlines and others
Check out the companies making headlines before the bell: Kellogg (K) – Kellogg jumped 8.1% in premarket trading after announcing plans to split into three separate public companies. One entity will comprise the snack and international cereal businesses, another the U.S. cereal business and the third will be a pure-play plant-based food producer. Lennar (LEN) […]
Read More
Kevin O’Leary names 3 companies to invest in: These are ‘not going to zero’
It’s a tough year to be invested in stocks, with the stock market experiencing a seemingly never-ending cycle of gyrations. Major U.S. indexes fell last week, with the Dow Jones Industrial Average ending the week at 29,888.78 — just a day after it dipped below the key 30,000 level for the first time since January […]
Read More
CDC advisors recommend Covid vaccines for children as young as 6 months
A child is administered a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) pediatric vaccine. Mayela Lopez | Reuters The Centers for Disease Control and Prevention’s independent vaccine experts on Saturday backed Pfizer’s and Moderna’s Covid-19 shots for children as young as 6 months. The CDC committee voted unanimously to recommend the shots for use in […]
Read More
FDA authorizes Pfizer and Moderna’s Covid vaccines for children as young as 6 months
The Food and Drug Administration on Friday authorized Moderna’s and Pfizer’s Covid-19 shots for children as young as 6 months old, which makes nearly every person in the U.S. now eligible for vaccination. The FDA decision comes after its committee of independent vaccine experts voted unanimously to recommend the shots after weighing their safety and […]
Read More
Florida is the only state that hasn’t ordered Covid vaccines for kids under 5
Parents walk their children on the first day of school, amid the coronavirus (COVID-19) pandemic, at West Tampa Elementary School in Tampa, Florida, U.S., August 10, 2021. Octavio Jones | Reuters Florida parents with kids under 5 years old may find themselves waiting longer than the rest of the country to get their youngest children vaccinated […]
Read More
EU drugs watchdog launches rolling review of Pfizer-BioNTech’s Covid variant vaccine
A registered nurse prepares a dose of the Pfizer COVID-19 vaccine. Mario Tama | Getty Images The European Medicines Agency on Wednesday launched a rolling review of a variant-adapted Covid-19 vaccine developed by Pfizer and BioNTech, as cases of new sub-variants of the coronavirus’s Omicron lineage rise. When available, clinical trial data will be added […]
Read More
FDA committee recommends Moderna two-dose Covid vaccine for kids ages 6 to 17
A young man receives his Covid-19 vaccination at a vaccination clinic. People receive the Moderna vaccine in Milford, Pennsylvania. Preston Ehrler | LightRocket | Getty Images Moderna’s two-dose Covid-19 vaccine for kids ages 6 through 17 received the endorsement from the Food and Drug Administration’s committee of independent immunization experts on Tuesday, a key step […]
Read More
Signs point to biotech M&A heating up, Wells Fargo says. Here’s where to look
The pace of biotech deals is likely to pick up, but investors should think about smaller targets, said Wells Fargo analyst Mohit Bansal. Bansal called out both enticing valuations for small- and mid-cap biotech companies, which are now trading at an enterprise value of about one times cash, on average, and a tough regulatory environment […]
Read More